# Comparison of Sugammadex and Neostigmine During PACU Stay

> **NCT04096144** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of South Florida** · enrollment: 50 (estimated)

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Neuromuscular Blocking Agents

## Key facts

- **NCT ID:** NCT04096144
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2019-10-15
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-06-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096144, "Comparison of Sugammadex and Neostigmine During PACU Stay". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04096144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*